Abstract
Human T-lymphotropic virus 1 (HTLV-1) infection has been associated with ATL and inflammatory diseases but remains a neglected health problem. HTLV-1 associated diseases were originally described as sporadic entities, but family aggregations have been reported. Viral, genetic, immunological and behavioral factors were used to explain family clusters, but until now a clear explanation remains uncertain. In the present study we report, for the first time, a family cluster of diseased persons presenting the infection across three generations associated with FAS -670A/G polymorphism.
Introduction
HumanT-lymphotropic virus 1 (HTLV-1) is a human retrovirus that causes lifelong infection (Poiesz et al., 1981; Bangham and Matsuoka, 2017). Recent estimate suggests that there are 5–10 million infected persons worldwide but its geographical distribution is heterogeneous, with the infection occurring in Japan, Australo-Melanesia, Caribbean, North and South America, Europe, Central, South and West Africa (Gessain and Cassar, 2012).
Although the infection has been associated with inflammatory and lymphoproliferative diseases (Bangham and Matsuoka, 2017) it remains a neglected health problem and many questions remain unsolved. It is not known why most HTLV-1-infected persons remain asymptomatic and 10% of them develop clinical symptoms (Kaplan et al., 1990). The presence of the virus is not the only variable associated with disease development once most of people infected with HTLV-1 remain asymptomatic.
Human T-lymphotropic virus 1 (HTLV-1) associated diseases were originally described as sporadic entities, but family clusters have been long reported worldwide (Ishak et al., 1995; da Costa et al., 2013; Alvarez et al., 2016; Frutos et al., 2017). Members of the same family share transmission routes of infection, virus genotypes, host genetic background, and environmental factors that increase the risk for family aggregation of the virus infection and associated diseases.
The search for host immunogenetic markers, possibly associated with HTLV-1 infection and progression to disease was pursued by our research group in the Amazon region of Brazil and other groups elsewhere (Nishimura et al., 1991; Jeffery et al., 2000; Pontes et al., 2005; Alves et al., 2007; Vallinoto et al., 2012, 2015; de Sá et al., 2016; Rosado et al., 2017). Polymorphisms rs1800450 (allele B, codon 54) and rs1800682 (-670A/G) located in MBL2 and FAS genes, respectively, were strongly associated with HTLV-1 infection. MBL2∗B allele was associated with higher proviral load, a viral biomarker of disease outcome. Similarly, FAS -670A/G single nucleotide polymorphism allele ∗G was more frequent among HTLV-1 asymptomatic infected persons and allele ∗A was more prevalent among those with clinical neurological symptoms diagnosed as HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP). The present study aimed to investigate if a family aggregation of HTLV-1 infection could be associated with FAS and MBL2 gene polymorphisms.
Case Report
The study was approved by the Research Ethics Committee of the University Hospital João de Barros Barreto from the Universidade Federal do Pará (process No. 2061/2005). Participants were fully informed about the research objectives, and those who agreed to participate signed an informed consent form.
Figure 1 and Table 1 describe a three generation family, from the Northern of Brazil (Amazon region), which included six members (five females and one male; index case #25697). HTLV-1 infection was investigated in the plasma and cells of blood samples. An enzyme immune assay was used for the detection of antibodies to HTLV-1/2 in the plasma. Positive samples were submitted to DNA extraction from PBMC using the purification kit GFX for genomic DNA (Amersham Pharmacia Biotech, Inc., United States) and assayed using nested PCR and qPCR to confirm the infection, as previously described (da Costa et al., 2013). FAS and MBL2 gene polymorphisms were identified using a PCR method, as previously described (Pontes et al., 2005; Vallinoto et al., 2012).
FIGURE 1
Table 1
| Subject | Sex | Age | Kinship | Generation (°) | MBL2 | FAS -670 | Clinic outcome | PVL |
|---|---|---|---|---|---|---|---|---|
| #25697∗ | Female | 61 | – | 2° | AA | AG | HAM/TSP | 4529.8 |
| #25696 | Female | 54 | Sister | 2° | AA | AA | HAM/TSP | 2437.7 |
| #25701 | Female | 65 | Sister | 2° | AB | AG | Uveitis | 1215.0 |
| #25703 | Female | 72 | Sister | 2° | AB | GG | Asymptomatic | 1557.7 |
| #25702 | Female | 49 | Niece | 3° | AA | GG | Asymptomatic | 2652.3 |
| #25704 | Male | 47 | Nephew | 3° | AB | GG | Asymptomatic | 569.0 |
Demographic genetic and clinical information of the HTLV-1 infected family members investigated.
∗Index case; PVL, proviral load (copies of DNA proviral/mm3).
Infection with HTLV-1 subtype Cosmopolitan, subgroup Transcontinental, was confirmed in the six investigated members of the family, according to the homology to sequences deposited in the NCBI - National Center for Biotechnology Information website1.
Three members of the family were asymptomatic, two presented HAM/TSP and one with uveitis. Although the precise route of transmission was not known breastfeeding was the most probable route as two sisters reported to have been breastfed by the already deceased mother. One of the four sisters (#25703) was an asymptomatic married HTLV-1 carrier, who breastfed her two children and both were also asymptomatic HTLV-1 carriers.
MBL2 gene polymorphism analysis showed the presence of AA wild genotype in three subjects. The allele MBL2∗B (rs1800450), carried by heterozygous genotype (AB), was observed in two sisters (second generation) and in one male of the third generation (Figure 1).
The investigation of FAS -670A/G polymorphism showed that five members of the family (83%) carried the allele ∗G; three of them were asymptomatic homozygous GG and two were symptomatic heterozygous AG, one with a clinical diagnosis of uveitis and the other with HAM/TSP. One of the females with HAM/TSP was a carrier of AA genotype. The allele ∗G was more frequent among the asymptomatic persons, but the allele ∗A, was present among the three symptomatic sisters.
Discussion
MBL is an important acute-phase serum protein involved in the innate immune response that can trigger complement activation (Wong et al., 1999), and an association between allele ∗B in the exon 1 of the MBL2 gene has been reported with the occurrence of immunodeficiency and chronic infectious diseases (Turner, 2003; Vallinoto et al., 2006). In our previous report, allele ∗B was associated with higher proviral load, a biomarker of clinical progression for HTLV-1 associated diseases. One of the three family members carrying the allele ∗B exhibited clinical symptoms of uveitis. The outcome of the other two asymptomatic carriers is still inconclusive and requires a follow up. However, two symptomatic HTLV-1 siblings (#25696 and #25697) carry the genotype AA, suggesting that there are other contributing factors for the progression of disease, apart from MBL2 gene SNP.
FAS -670A/G polymorphism was investigated and the allele ∗G was more frequent among the asymptomatic persons. Allele ∗A, was present in three symptomatic sisters, supporting our previous report that showed higher frequency of allele ∗A among HAM/TSP patients as compared to HTLV-1 asymptomatic persons (Vallinoto et al., 2012). The physical location of a SNP of FAS (-670A/G) favor its binding to the site of the signal transducer and activator of transcription (STAT1), which would be sufficient for the up and down regulation of FAS gene (Wang et al., 2016). Our previous report describes a strong association between this SNP and HTLV-1 infection and suggests that persons with FAS -670GG genotype may have a lower affinity to STAT1 binding as compared to infected persons carrying the FAS -670AA genotype. The presence of the SNP may lead to a decrease or increase of the apoptotic potential of the FAS receptor among patients carrying FAS -670GG and AA genotypes, respectively (Vallinoto et al., 2012). Farre et al. (2008) showed that the FAS promoter polymorphism is associated with the clinical manifestation and survival of HTLV-1 patients presenting adult T-cell leukemia – ATL. Among HAM/TSP patients, FAS levels correlated positively with lymphocyte activation, but the increased lymphocyte FAS expression was linked to decreased apoptosis and increased lymphoproliferation in cell culture and a strong increase in cellular FAS expression upon HAM/TSP progression (Menezes et al., 2017). Moreover, Rosado et al. (2017) found an association between the FAS -670 AA genotype and the higher proviral load among HAM/TSP patients.
It is important to point out that although familial aggregation of HTLV-1 infection and disease is not a recently described characteristic of the natural history of the virus, there are few attempts to characterize associated biomarkers, which favor the clustering of cases and define the outcome of the infection. FAS -670A/G polymorphism seems to be a reliable indicator to pursue involving larger numbers of other families with HTLV-1 aggregation. This would certainly help to assist toward prevention of the virus spread.
Statements
Author contributions
Conceived and designed the experiments: AV, MS, and RI; wrote the paper: AV, IC-V, and RI; assisted with editing the paper: MQ, AS, and IC-V; performed the experiments: BS, CC, and MQ; analyzed the data: AV, BS, RI, and MS; contributed reagents/materials/analysis tools: AV, MS, and RI.
Funding
The present study was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico – CNPq (302582/2013-4 and 459352/2014-8) and Pró-Reitoria de Pesquisa e Pós-Graduação (PROPESP/UFPA) and Pró-Reitoria de Extensão (PROEX/UFPA).
Acknowledgments
The authors thank all the family members who accepted to take part of the present study.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. At the time of acceptance, the handling Editor declared a shared affiliation, though no other collaboration, with the authors.
Footnotes
References
1
AlvarezC.GotuzzoE.VandammeA. M.VerdonckK. (2016). Family aggregation of human T-Lymphotropic virus 1-associated diseases: a systematic review.Front. Microbiol.7:1674. 10.3389/fmicb.2016.01674
2
AlvesA. E.HermesR. B.Tamegão-LopesB.MachadoL. F.AzevedoV. N.IshakM. O.et al (2007). Polymorphism in the promoter region of the mannose-binding lectin gene among human T-cell lymphotropic virus infected subjects.Mem. Inst. Oswaldo Cruz102991–994. 10.1590/S0074-02762007000800015
3
BanghamC. R. M.MatsuokaM. (2017). Human T-cell leukaemia virus type 1: parasitism and pathogenesis.Philos. Trans. R. Soc. Lond. B Biol. Sci.372:20160272. 10.1098/rstb.2016.0272
4
da CostaC. A.FurtadoK. C.FerreiraL. S.AlmeidaD. S.LinharesA. C.IshakR.et al (2013). Familial transmission of human T-cell lymphotropic virus: silent dissemination of an emerging but neglected infection.PLOS Negl. Trop. Dis.7:e2272. 10.1371/journal.pntd.0002272
5
de SáK. S.SantanaB. B.de Souza FerreiraT. C.SousaR. C.CaldasC. A.AzevedoV. N.et al (2016). IL28B gene polymorphisms and Th1/Th2 cytokine levels might be associated with HTLV-associated arthropathy.Cytokine7779–87. 10.1016/j.cyto.2015.11.004
6
FarreL.BittencourtA. L.Silva-SantosG.AlmeidaA.SilvaA. C.DecanineD.et al (2008). Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.J. Leukoc. Biol.83220–222. 10.1189/jlb.0407198
7
FrutosM. C.GastaldelloR.BalangeroM.RemondeguiC.BlancoS.OtsukiK.et al (2017). Silent dissemination of HTLV-1 in an endemic area of Argentina. Epidemiological and molecular evidence of intrafamilial transmission.PLOS ONE12:e0174920. 10.1371/journal.pone.0174920
8
GessainA.CassarO. (2012). Epidemiological aspects and world distribution of HTLV-1 infection.Front. Microbiol.3:388. 10.3389/fmicb.2012.00388
9
IshakR.HarringtonW. J.Jr.AzevedoV. N.EirakuN.IshakM. O. G.GuerreiroJ. F.et al (1995). Identification of human T-cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil.AIDS Res. Hum. Retroviruses11813–821. 10.1089/aid.1995.11.813
10
JefferyK. J.SiddiquiA. A.BunceM.LloydA. L.VineA. M.WitkoverA. D.et al (2000). The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.J. Immunol.1657278–7284. 10.4049/jimmunol.165.12.7278
11
KaplanJ. E.OsameM.KubotaH.IgataA.NishitaniH.MaedaY.et al (1990). The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.J. Acquir. Immune Defic. Syndr.31096–1101.
12
MenezesS. M.LealF. E.DierckxT.KhouriR.DecanineD.Silva-SantosG.et al (2017). A fashi lymphoproliferative phenotype reveals non-apoptotic fas signaling in HTLV-1-associated neuroinflammation.Front. Immunol.8:97. 10.3389/fimmu.2017.00097
13
NishimuraY.OkuboR.MinatoS.ItoyamaY.GotoI.MoriM.et al (1991). A possible association between HLA and HTLV-I-associated myelopathy (HAM) in Japanese.Tissue Antigens37230–231. 10.1111/j.1399-0039.1991.tb01877.x
14
PoieszB. J.RuscettiF. W.ReitzM. S.KalyanaramanV. S.GalloR. C. (1981). Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.Nature294268–271. 10.1038/294268a0
15
PontesG. S.Tamegão-LopesB.MachadoL. F.AzevedoV. N.IshakM. O.IshakR.et al (2005). Characterization of mannose-binding lectin gene polymorphism among human T-cell lymphotropic virus 1 and 2–infected asymptomatic subjects.Hum. Immunol.66892–896. 10.1016/j.humimm.2005.06.006
16
RosadoJ.MoralesS.LópezG.ClarkD.VerdonckK.GotuzzoE.et al (2017). The FAS-670 AA genotype is associated with high proviral load in peruvian HAM/TSP patients.J. Med. Virol.89726–731. 10.1002/jmv.24681
17
TurnerM. W. (2003). The role of mannose-binding lectin in health and disease.Mol. Immnunol.40423–429. 10.1016/S0161-5890(03)00155-X
18
VallinotoA. C.Menezes-CostaM. R.AlvesA. E.MachadoL. F.de AzevedoV. N.SouzaL. L.et al (2006). Mannose-binding lectin gene polymorphism and its impact on human immunodeficiency virus 1 infection.Mol. Immunol.431358–1362. 10.1016/j.molimm.2005.09.001
19
VallinotoA. C.SantanaB. B.dos SantosE. L.SantoR. R.HermesR. B.SousaR. C.et al (2012). FAS -670A/G single nucleotide polymorphism may be associated with human T lymphotropic virus-1 infection and clinical evolution to TSP/HAM.Virus Res.163178–182. 10.1016/j.virusres.2011.09.015
20
VallinotoA. C.SantanaB. B.SáK. S.FerreiraT. C.SousaR. C.AzevedoV. N.et al (2015). HTLV-1-associated myelopathy/tropical spastic paraparesis is not associated with SNP rs12979860 of the IL-28B gene.Mediators Inflamm.2015:804167. 10.1155/2015/804167
21
WangS.WuS.MengQ.LiX.ZhangJ.ChenR.et al (2016). FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin.Sci. Rep.6:19229. 10.1038/srep19229
22
WongN. K.KojimaM.DobóJ.AmbrusG.SimR. B. (1999). Activities of the MBL-associated serine proteases (MASPs) and their regulation by natural inhibitors.Mol. Immunol.36853–861. 10.1016/S0161-5890(99)00106-6
Summary
Keywords
human T-lymphotropic virus 1, family cluster, FAS gene, MBL gene, genetic polymorphism
Citation
Vallinoto ACR, Santana BB, Queiroz MAF, da Silva ANMR, Cayres-Vallinoto IMV, da Costa CA, de Sousa MS and Ishak R (2018) Family Aggregation of HTLV-1 Infection Associated with FAS -670A/G Polymorphism: A Case Report. Front. Microbiol. 8:2685. doi: 10.3389/fmicb.2017.02685
Received
17 November 2017
Accepted
26 December 2017
Published
15 January 2018
Volume
8 - 2017
Edited by
Juarez Antonio Simões Quaresma, Instituto Evandro Chagas, Brazil
Reviewed by
Renaud Mahieux, École cole Normale Supérieure de Lyon, France; Anne-Mieke Vandamme, KU Leuven, Belgium; Maria Grazia Romanelli, University of Verona, Italy
Updates
Copyright
© 2018 Vallinoto, Santana, Queiroz, da Silva, Cayres-Vallinoto, da Costa, de Sousa and Ishak.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Antonio C. R. Vallinoto, vallinoto@ufpa.br
This article was submitted to Microbial Immunology, a section of the journal Frontiers in Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.